- Pharma
- January 2, 2025
- 91 views
Kwality Pharma gains on securing RCGM approval for Erythropoietin
Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…
- Policy
- October 31, 2018
- 119 views
New Tuberculosis drug ‘Bedaquiline’ gave side effects on 8% of its users
Report generated from the data gathered through RTI Act revealed that the new tuberculosis drug ‘Bedaquiline’ at public hospitals over the last two years experienced side-effects like depression, liver damage,…